BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 28576284)

  • 1. Congenital adrenal hyperplasia.
    El-Maouche D; Arlt W; Merke DP
    Lancet; 2017 Nov; 390(10108):2194-2210. PubMed ID: 28576284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital adrenal hyperplasia.
    Auer MK; Nordenström A; Lajic S; Reisch N
    Lancet; 2023 Jan; 401(10372):227-244. PubMed ID: 36502822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution therapy in adult patients with congenital adrenal hyperplasia.
    Reisch N
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):33-45. PubMed ID: 25617171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital Adrenal Hyperplasia.
    Fraga NR; Minaeian N; Kim MS
    Pediatr Rev; 2024 Feb; 45(2):74-84. PubMed ID: 38296783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Steroid 21-hydroxylase deficiency, the most frequent cause of congenital adrenal hyperplasia].
    Doleschall M; Török D; Mészáros K; Luczay A; Halász Z; Németh K; Szücs N; Kiss R; Tőke J; Sólyom J; Fekete G; Patócs A; Igaz P; Tóth M
    Orv Hetil; 2018 Feb; 159(7):269-277. PubMed ID: 29429350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.
    Carmina E; Dewailly D; Escobar-Morreale HF; Kelestimur F; Moran C; Oberfield S; Witchel SF; Azziz R
    Hum Reprod Update; 2017 Sep; 23(5):580-599. PubMed ID: 28582566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency.
    Webb EA; Krone N
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):449-68. PubMed ID: 26051302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of classical congenital adrenal hyperplasia.
    Marumudi E; Khadgawat R; Surana V; Shabir I; Joseph A; Ammini AC
    Steroids; 2013 Aug; 78(8):741-6. PubMed ID: 23624029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal steroidogenesis and congenital adrenal hyperplasia.
    Turcu AF; Auchus RJ
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):275-96. PubMed ID: 26038201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.
    Bulsari K; Falhammar H
    Endocrine; 2017 Jan; 55(1):19-36. PubMed ID: 27928728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Advances in the Management of Congenital Adrenal Hyperplasia.
    Bouliari A; Bullard F; Lin-Su K; Lekarev O
    Adv Pediatr; 2024 Aug; 71(1):135-149. PubMed ID: 38944479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital adrenal hyperplasia].
    Stanić M; Nesović M
    Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
    Ambroziak U; Bednarczuk T; Ginalska-Malinowska M; Małunowicz EM; Grzechocińska B; Kamiński P; Bablok L; Przedlacki J; Bar-Andziak E
    Endokrynol Pol; 2010; 61 Suppl 1():7-21. PubMed ID: 22127631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term morbidity in congenital adrenal hyperplasia].
    Tschaidse L; Quitter F; Hübner A; Reisch N
    Internist (Berl); 2022 Jan; 63(1):43-50. PubMed ID: 34978615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Forest MG
    Hum Reprod Update; 2004; 10(6):469-85. PubMed ID: 15514016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
    Kopacek C; Prado MJ; da Silva CMD; de Castro SM; Beltrão LA; Vargas PR; Grandi T; Rossetti MLR; Spritzer PM
    J Pediatr (Rio J); 2019; 95(3):282-290. PubMed ID: 29715434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency - the next disease included in the neonatal screening program in Poland.
    Ginalska-Malinowska M
    Dev Period Med; 2018; 22(2):197-200. PubMed ID: 30056407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital adrenal hyperplasia: not really a zebra.
    Deaton MA; Glorioso JE; McLean DB
    Am Fam Physician; 1999 Mar; 59(5):1190-6, 1172. PubMed ID: 10088875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country.
    Utari A; Faradz SMH; Ediati A; Rinne T; Ariani MD; Juniarto AZ; Drop SLS; van Herwaarden AE; Claahsen-van der Grinten HL
    Front Endocrinol (Lausanne); 2022; 13():1015973. PubMed ID: 36589846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.